The Indianapolis-based health insurance company will report its earnings results before the market open on Wednesday.
Analysts surveyed by Thomson Reuters are expecting the company to report earnings of $1.22 per share on revenue of $19.9 billion.
Anthem reported earnings of $1.73 per share on revenue in the 2014 fourth quarter. Revenue rose 6.4% to $18.8 billion in the year-ago period.
Earlier this year, Anthem announced at a conference that it expects a 10% rise in profits during 2016, according to Bloomberg.
The news calmed investors who were concerned about the impact of the Affordable Care Act on health care companies, Bloomberg reported.
Separately, recently, TheStreet Ratings objectively rated this stock according to its "risk-adjusted" total return prospect over a 12-month investment horizon. Not based on the news in any given day, the rating may differ from Jim Cramer's view or that of this articles's author.
TheStreet Ratings rates this stock as a "buy" with a ratings score of A-. This is based on the convergence of positive investment measures, which should help this stock outperform the majority of stocks that we rate. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, increase in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures and attractive valuation levels. We feel its strengths outweigh the fact that the company shows weak operating cash flow.
You can view the full analysis from the report here: ANTM